Oscar Health, Inc. Class A Common Stock (NY:OSCR)

31.66 +0.67 (+2.15%)

Delayed Quote Updated: 10:59 AM EDT, Oct 26, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Oscar Health, Inc. Class A Common Stock

< Previous 1 2

...

5 6 7 8 9 10 11 12 13

...

24 25 Next >

What's Going On With Oscar Health Stock On Wednesday? ↗

August 20, 2025

Oscar Health shares fell despite no direct news as the company reported Q2 losses, reaffirmed sales guidance, and launched a new plan with Hy-Vee.

Via Benzinga

3 Stocks to Buy That Could Explode Soon ↗

August 19, 2025

Here are three stocks to buy now that could offer investors upside in the long term.

Via The Motley Fool

10 Financials Stocks With Whale Alerts In Today's Session ↗

August 18, 2025

Via Benzinga

Why Oscar Health (OSCR) Stock Is Up Today

August 15, 2025

Shares of health insurance company Oscar Health (NYSE:OSCR) jumped 7.1% in the morning session after continued positive momentum as it announced a partnership to launch a new health insurance plan with...

Via StockStory

Analyst Expectations For Oscar Health's Future ↗

August 14, 2025

Via Benzinga

Earnings Scheduled For August 6, 2025 ↗

August 06, 2025

Via Benzinga

Earnings Outlook For Oscar Health ↗

August 05, 2025

Via Benzinga

Oscar Health Now Expects Loss From Operations Of $200M To $300M In 2025: Here’s What Retail Thinks About The Stock Price ↗

July 22, 2025

Via Stocktwits

Evolv Technologies, Precigen, Hesai Group And Other Big Stocks Moving Higher On Friday ↗

August 15, 2025

Via Benzinga

Oscar Health Faces Analyst Questions On Path To Profitability ↗

August 14, 2025

Oscar Health keeps 2025 risk adjustment guidance steady as Piper Sandler trims price target to $13, citing profitability uncertainty.

Via Benzinga

Hy-Vee Health and Oscar Serve Up a New Era of Employer Healthcare

August 14, 2025

From Oscar Health, Inc.

Via Business Wire

10 Financials Stocks Whale Activity In Today's Session ↗

August 12, 2025

Via Benzinga

OSCR Q2 Deep Dive: Market Morbidity Pressures Offset by Strategic Cost Actions and Product Expansion

August 12, 2025

Health insurance company Oscar Health (NYSE:OSCR) fell short of the market’s revenue expectations in Q2 CY2025, but sales rose 29% year on year to $2.86 billion. Its non-GAAP loss of $0.89 per share...

Via StockStory

Topics Economy

10 Financials Stocks Whale Activity In Today's Session ↗

August 11, 2025

Via Benzinga

Here's Why I Am Buying More Shares of Oscar Health After Earnings ↗

August 08, 2025

Management seems very confident in reaching its near-term targets.

Via The Motley Fool

10 Financials Stocks Whale Activity In Today's Session ↗

August 07, 2025

Via Benzinga

Oscar Health (OSCR) Q2 Revenue Rises 29% ↗

August 06, 2025

Via The Motley Fool

10 Financials Stocks With Whale Alerts In Today's Session ↗

August 06, 2025

Via Benzinga

Oscar Health Well-Positioned To Manage Market Reset, Eyes Profitability In 2026 ↗

August 06, 2025

Via Benzinga

Oscar Health (NYSE:OSCR) Misses Q2 Sales Targets

August 06, 2025

Health insurance company Oscar Health (NYSE:OSCR) fell short of the market’s revenue expectations in Q2 CY2025, but sales rose 29% year on year to $2.86 billion. Its GAAP loss of $0.89 per share was in...

Via StockStory

Oscar Health Announces Financial Results for Second Quarter 2025 and Reaffirms Updated 2025 Guidance

August 06, 2025

From Oscar Health, Inc.

Via Business Wire

Oscar Health (OSCR) Q2 Earnings: What To Expect

August 04, 2025

Health insurance company Oscar Health (NYSE:OSCR) will be reporting earnings this Wednesday morning. Here’s what to expect.

Via StockStory

Topics Artificial Intelligence Government World Trade

10 Financials Stocks Whale Activity In Today's Session ↗

July 31, 2025

Via Benzinga

1 Profitable Stock with Exciting Potential and 2 We Turn Down

July 31, 2025

While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my...

Via StockStory

Oscar Health (OSCR): 3 Reasons We Love This Stock

July 30, 2025

Over the past six months, Oscar Health’s stock price fell to $13.90. Shareholders have lost 19.7% of their capital, which is disappointing considering the S&P 500 has climbed by 5%. This may have...

Via StockStory

Topics Government Stocks World Trade

Oscar Health, Surgery Partners, Moderna, Molina Healthcare, and Fortrea Stocks Trade Down, What You Need To Know

July 29, 2025

A number of stocks fell in the afternoon session after industry bellwether UnitedHealth Group (UNH) slashed its 2025 profit forecast after reporting a significant surge in medical costs, sending...

Via StockStory

2 Digital Healthcare Stocks Poised for a Breakout ↗

July 24, 2025

Digital disruptors are the future of the healthcare industry. Here are two stocks in the space to consider.

Via The Motley Fool

Topics Artificial Intelligence

History of Oscar Health, Inc.: Revolutionizing Health Insurance with Technology – Stock and Share Overview (NYSE:OSCR)

July 23, 2025

Oscar Health, Inc. (NYSE:OSCR) stands as a disruptive force in the American health insurance landscape, emerging as a pioneer at the crossroads of technology and healthcare. Since its inception in...

Via MarketMinute

Oscar Health Stock Outpaces Forecasts: Insurance Disruptor Gains Ground (NYSE:OSCR)

July 23, 2025

Oscar Health has once again asserted itself as a formidable disruptor in the insurance sector, with its stock posting robust gains after the company exceeded Wall Street’s expectations. The latest...

Via MarketMinute

Oscar Health Announces Preliminary Financial Results for Second Quarter 2025 and Revises 2025 Guidance

July 22, 2025

From Oscar Health, Inc.

Via Business Wire

< Previous 1 2

...

5 6 7 8 9 10 11 12 13

...

24 25 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.